AI-Powered oxygen device could revolutionize respiratory care
NCT ID NCT06952816
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new AI device called EMILY that automatically adjusts oxygen levels for people with acute or chronic respiratory failure. Researchers will enroll 20 adults in the hospital to see how well the device keeps oxygen in a safe range and how quickly it responds to changes. The goal is to improve patient safety and reduce the need for constant manual adjustments by medical staff.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario Fundación Jiménez Díaz
RECRUITINGMadrid, Spain
-
Hospital Universitario Fundación Jiménez Díaz
RECRUITINGMadrid, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple inhaled combo keep pneumonia patients off ventilators?
- Can a Diaphragm-Sensing ventilator mode reduce breathing asynchrony?
- New monitoring methods could make home ventilation safer and more comfortable
- Which oxygen strategy saves more lives? large trial puts three methods to the test
- Ultrasound may reveal hidden causes of ventilator weaning failure
- New anxiety program for ICU survivors shows promise in early trial